2Holm J, Nielsen NV, Hemmingsen L. Retinopathy in type Ⅱ diabetes mellitus associated with above-normal urinary excretion of RBP[J]. Kidney Int Suppl,1994,47S: 105-108.
8Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes[J]. Nature,2005,436(7049) :356-362.
9Kowalska I,Straczkowski M, Adamska A,et al. Serum retinol binding protein 4 is related to insulin resistance and nonoxidative glucose metabolism in lean and obese women with normal glucose tolerance[J]. J Clan Endocrinol Metab, 2008,93 (7) : 2786-2789.
6Meigs JB, Pan huysen CI, Myers RH, et al. A genomewide scanforloci linked to plasma levels of glucose and HbAlc in a community-based sample of caucasian pedigrees : The FramitIsham offspring Study. Diabetes Care, 2002, 25 (10) : 1845-1850.
7Tsutsumi C, Okuno M, Tannous L, et al. Retinoids and retinoid-binding protein expression in rat adipocytes. J Biol Chem, 1992, 267(3) : 1805-1810.
8Quadro L, Hamberger L, Colantuoni V, et al. Understanding the physiological role of retinolbinding protein in vitamin A metabolism using transgenic and knockout mouse models. Mol Aspects Med, 2003, 24(6) : 421-430.
9Bruzinick JT. GLUTg overexpression in db/db mice, lose dependently ameliorates diabetes but is not a life long cure. Diabetes, 2001, 50(3): 593-600.
10Yang Q, Graham TE, Mody M,et al. Serum retinol binding protein g contributes to insulin resistance in obesity and type2 diabetes. Nature, 2005,456 (7049) : 356 -362.
1OUCHI N, PARKER JL, LUGUS JJ, et al. Adipokines in inflammation and metabolic disease[ J]. Nat Rev Immuno1,2011, 11(2) :85 -97.
2AMERICAN DIABETES ASSOCIATION. Diagnosis and classification of diabetes mellitus [ J ]. Diabetes Care, 2014,37 ( Suppl 1 ) : S81 - 90.
3ASMATHULLA S, RAJAGOVINDAN D, SATHYAPRIYA V, et al. Prevalence of prehypertension and its relationship to cardiovascular disease risk factors in Puducherry [ J ]. Indian J Physiol Pharmaeo1,2011,55 (4) :343 - 350.
4FOX CS, MASSARO JM, HOFFMANN U, et al. Abdominal visceral and subcutaneous adipose tissue compartments : association with metabolic risk factors in the Framingham Heart Study [ J ]. Circulation,2007,1 t 6 ( 1 ) :39 - 48.
5COMIM FV, HARDY K, FRANKS S. Adiponectin and its receptors in the ovary :further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome [ J ]. PLoS One,2013,8( 11 ) :e80416.
6LEAL VDE O, MAFRA D. Adipokines in obesity. [ J ] Clin Chim Acta,2013 ,419 :87 -94.
7SUN Q, KIERNAN UA, SHI L, et al. Plasma retinol-binding protein 4 (RBP4) levels and risk of Coronary heart diseas. A prospective analysis among women in the nurses" health study [ J ]. Circulation,2013,127 (19) : 1938 - 1947.
8ZHOU Y, RUI L. Lipocalin 13 regulation of glucose and lipid metabolism in obesity[J]. Vitam Horm,2013,91:369 -383.
9BASTARD JP, MAACHI M, LAGATHU C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance[ J]. Eur Cytokine Netw,2006,17 ( 1 ) :4 - 12.
10PARK CS, IHM SH, PARK HJ, et al. Relationship between plasma adiponectin, retinol-binding protein 4 and uric Acid in hypertensive patients with metabolic syndrome [ J]. Korean Circ J,2011,41 (4) :198 -202.
